Zions Bancorporation, National Association’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669 Buy
7
+4
+133% +$364 ﹤0.01% 1503
2026
Q1
$289 Buy
+3
New +$300 ﹤0.01% 1504

Other funds holding IRMD

Zions Bancorporation, National Association's IRMD Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its iRadimed (IRMD) stake by 133% in Q2 2026, buying an estimated $364 and bringing the position to 7 shares worth $669. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Zions Bancorporation, National Association first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Zions Bancorporation, National Association held 7 shares of iRadimed worth $669 as of Q2 2026.
  • Zions Bancorporation, National Association bought 4 iRadimed shares in Q2 2026, an estimated $364.
  • iRadimed made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1503 holding.
  • Zions Bancorporation, National Association first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.